Home Home Cellular Therapies AABB Center for Cellular Therapies Cellular Therapies Section AABB HUB Consumer Information News Circular of Information for the Use of Cellular Therapy Products Revised DHQ for HPC, Apheresis and Marrow and Cord Blood Now Available ISBT 128 Compliance Audit Tool For Use With CT Products Cellular Therapies Certificate Program Human Platelet Lysate Project CellSource Professional Tools and Projects Events AABB Annual Meeting eCasts Transfusion Medicine Access Transfusion with yourAABB member login. News 2018 Ask the FDA and CLIA TranscriptIron Management Among Blood Donors Joint Comments to CMS on Proposed Changes to the Medicare Hospital Outpatient Prospective Payment System for 2019AABB Babesiosis Risk-Based Decision-Making Assessment ReportAABB Releases the 2014-2015 AABB Blood Survey Report Apply for a 2019 NBF Scientific Research Grant Resources Circular of Information for the Use of Human Blood and Blood Components Blood Donation Information Blood FAQ AABB HUB Emerging Infectious Disease Agents Donor History Questionnaires Transfusion News Clinical Resources Transfusion Medicine Section Patient Blood Management AABB is committed to providing premier patient blood management resources and services that can assist you and your institution in your efforts to improve the quality of the care you provide and, where possible, to promote evidence-based transfusion medicine best practices. Visit the AABB Patient Blood Management page to learn more. White Paper - Building a Better Patient Blood Management Program AABB/The Joint Commission PBM Certification PBM Certification Bundle View a video presentation on this popular resource. Additional Select Resources “The Evolving Paradigm of Patient Blood Management” — A “Transfusion” special themed issue AABB’s Choosing Wisely Statement Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB Patient blood management in cardiac surgery results in fewer transfusions and better outcome (doi/10.1111/trf.12946) (early view) Standards for a Patient Blood Management Program, 2nd edition AABB Transfusion Safety and PBM Subsection Contact the AABB Patient Blood Management Department Contact the AABB Patient Blood Management Department at pbm@aabb.org or +1.301.215.6550 to receive expert advice about ways to engage your colleagues and key clinical leadership to either initiate a patient blood management program or gain momentum within your current program efforts. Calendar of Events Patient Identification at the Time of Specimen Collection - Options for Error Prevention (#19EL-400)January 16, 2019AABB eCast AABB Annual Meeting Highlights Conference and Exhibition in the Middle East 2019January 25-26, 2019 Disaster Management - Inventory Management/Staffing (#19EL-403)January 30, 2019AABB eCast TACO and Beyond (#18EL-362)February 5, 2019AABB eCast When Should We Culture Transfusion Reactions? Results from the SCARED Study (#19EL-405)February 6, 2019AABB eCast Perinatal and Cord Tissue Products (#19EL-406)February 14, 2019AABB eCast Platelet Inventory Management (#19EL-407)February 20, 2019AABB eCast Climate Change – Implication for the Infectious Safety of Blood, Cells and Tissues (#19EL-408)February 21, 2019AABB eCast Immunohematology Boot Camp Series: Monoclonal Antibody Therapy Interference and How to Avoid It (#19EL-402)February 27, 2019AABB eCast PBM Strategies in the Surgical Suite (#19EL-409)February 28, 2019AABB eCast (Hidden) Events 10 / 29 / 2013Event 3 Longer Title10 / 17 / 2013Event 210 / 07 / 2013Event 1 (Hidden) Zika Virus (Hidden) AABB 2015 Annual Meeting Blog Read about what happened in Anaheim What's New AABB News - January 2019AABB Weekly Report - January 11, 2019 Hemovigilance Update - Winter 2019 Joint Comments to FDA on “Recommendations for Requalification of Blood Donors Deferred Because of Reactive Test Results for Antibodies to Human T-Lymphotropic Virus Types I and II (anti-HTLV-I/II); Draft Guidance for Industry” Joint Comments to FDA on “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Draft Guidance for Industry” 2018 Ask the FDA and CLIA Transcript National Blood Foundation Awards 2018 Early-Career Grants to Seven Researchers Comments to FDA on “Long Term Follow-Up After Administration of Human Gene Therapy Products; Draft Guidance for Industry” Joint Letter to Congress Supporting the Blood-Related Provisions in the Pandemic and All-Hazards Preparedness & Advancing Innovation Act AABB HUB (Hidden) AABB Community Recommended Change to 29th Ed. BBTS Standards5/21/15 Expiration Date of a Unit5/18/15 Group O Policy4/24/15 Tweets by @AABB